ProfileGDS4718 / 204731_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 70% 71% 97% 66% 77% 84% 61% 62% 84% 72% 70% 74% 37% 64% 39% 76% 76% 50% 69% 69% 73% 79% 69% 80% 74% 71% 82% 72% 72% 49% 71% 73% 64% 43% 81% 83% 20% 77% 56% 96% 71% 77% 81% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.8702370
GSM549102patient 115, normal, homogenized [OPG study]6.9010271
GSM549104patient 119, normal, homogenized [OPG study]10.907697
GSM549108patient 138, normal, homogenized [OPG study]6.5454566
GSM549119patient 077, normal, homogenized [OPG study]7.4620677
GSM549133patient 032, cancer, homogenized [OPG study]8.5293784
GSM549139patient 042, cancer, homogenized [OPG study]6.2165561
GSM549099patient 107, normal, homogenized [OPG study]6.2484362
GSM549109patient 139, normal, homogenized [OPG study]8.257184
GSM549110patient 046, normal, homogenized [OPG study]6.9775272
GSM549114patient 063, normal, homogenized [OPG study]6.8250270
GSM549122patient 082, normal, homogenized [OPG study]7.2166974
GSM549134patient 033, cancer, homogenized [OPG study]4.8230537
GSM549136patient 036, cancer, homogenized [OPG study]6.3720164
GSM549140patient 044, cancer, homogenized [OPG study]4.87739
GSM549111patient 047, normal, homogenized [OPG study]7.4742676
GSM549113patient 057, normal, homogenized [OPG study]7.4688476
GSM549132patient 031, cancer, homogenized [OPG study]5.5095750
GSM549137patient 038, cancer, homogenized [OPG study]6.8164369
GSM549142patient 047, cancer, homogenized [OPG study]6.7867169
GSM549100patient 110, normal, homogenized [OPG study]7.1262373
GSM549107patient 135, normal, homogenized [OPG study]7.7791579
GSM549115patient 068, normal, homogenized [OPG study]6.771769
GSM549116patient 072, normal, homogenized [OPG study]7.8726180
GSM549120patient 078, normal, homogenized [OPG study]7.2119674
GSM549131patient 030, cancer, homogenized [OPG study]7.0279271
GSM549118patient 074, normal, homogenized [OPG study]8.1678982
GSM549129patient 027, cancer, homogenized [OPG study]7.0870772
GSM549123patient 088, normal, homogenized [OPG study]7.063572
GSM549124patient 006, cancer, homogenized [OPG study]5.4933849
GSM549126patient 015, cancer, homogenized [OPG study]6.953271
GSM549128patient 025, cancer, homogenized [OPG study]7.1837873
GSM549103patient 117, normal, homogenized [OPG study]6.4101264
GSM549117patient 073, normal, homogenized [OPG study]5.0980943
GSM549138patient 041, cancer, homogenized [OPG study]7.9613281
GSM549141patient 045, cancer, homogenized [OPG study]8.3223283
GSM549130patient 028, cancer, homogenized [OPG study]4.154420
GSM549101patient 111, normal, homogenized [OPG study]7.5207877
GSM549105patient 128, normal, homogenized [OPG study]5.8684656
GSM549106patient 134, normal, homogenized [OPG study]10.809396
GSM549112patient 048, normal, homogenized [OPG study]6.9389971
GSM549125patient 011, cancer, homogenized [OPG study]7.4726177
GSM549127patient 024, cancer, homogenized [OPG study]8.0106481
GSM549135patient 035, cancer, homogenized [OPG study]5.5272351